tiprankstipranks
Trending News
More News >
Radiopharm Theranostics Limited Sponsored ADR (RADX)
NASDAQ:RADX
US Market

Radiopharm Theranostics Limited Sponsored ADR (RADX) Income Statement

Compare
51 Followers

Radiopharm Theranostics Limited Sponsored ADR Income Statement

See RADX’s key income statement, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 3.63MAU$ 299.23KAU$ 292.36KAU$ 8.83K
Gross Profit
AU$ 39.28KAU$ 299.23KAU$ 292.36KAU$ 8.83K
Operating Expenses
AU$ 38.21MAU$ 36.92MAU$ 34.80MAU$ 19.93M
Depreciation and Amortization
AU$ 7.33KAU$ 3.13MAU$ 3.30MAU$ 2.98M
EBITDA
AU$ -38.17MAU$ -44.08MAU$ -31.19MAU$ -17.96M
Operating Income
AU$ -38.17MAU$ -36.62MAU$ -34.51MAU$ -19.92M
Other Income/Expenses
AU$ -65.30KAU$ -11.23MAU$ -65.10KAU$ -10.38M
Pretax Income
AU$ -38.24MAU$ -47.85MAU$ -34.57MAU$ -30.29M
Net Income
AU$ -38.34MAU$ -47.95MAU$ -34.61MAU$ -30.34M
Per Share Metrics
Basic EPS
AU$ -5.28AU$ -36.00AU$ -33.00AU$ -29.76
Diluted EPS
AU$ -5.28AU$ -36.00AU$ -33.00AU$ -29.76
Weighted Average Shares Outstanding
6.94M 1.29M 1.02M 1.02M
Weighted Average Shares Outstanding (Diluted)
6.94M 1.29M 1.02M 1.02M
Currency in AUD

Radiopharm Theranostics Limited Sponsored ADR Earnings and Revenue History